Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MPI | P34949 | 1/20 | 0.49 |
| ▸ | PGK1 | P00558 | 1/20 | 0.47 |
| ▸ | PGK2 | P07205 | 1/20 | 0.47 |
| ▸ | PGD | P52209 | 4/20 | 0.44 |
| ▸ | LPAR1 | Q92633 | 4/20 | 0.35 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.35 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.35 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.35 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.35 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.35 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.35 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1395698 | 0.85 | MPI (0.63) | MPIPGK1PGK2PGDLPAR1 | |
| SCHEMBL28125367 | 0.85 | MPI (0.63) | MPIPGK1PGK2PGDLPAR1 | |
| SCHEMBL10709491 | 0.85 | MPI (0.63) | MPIPGK1PGK2PGDLPAR1 | |
| SCHEMBL328992 | 0.85 | MPI (0.63) | MPIPGK1PGK2PGDLPAR1 | |
| SCHEMBL34088 | 0.85 | MPI (0.63) | MPIPGK1PGK2PGDLPAR1 | |
| Phosphoric Acid SCHEMBL6754811 | 0.83 | MPI (0.61) | MPIPGK1PGK2PGDLPAR1 | |
| Ammonia Solution, Strong SCHEMBL28280469 | 0.83 | MPI (0.61) | MPIPGK1PGK2PGDLPAR1 | |
| Phosphoric Acid SCHEMBL17103808 | 0.83 | MPI (0.61) | MPIPGK1PGK2PGDLPAR1 | |
| SCHEMBL10794963 | 0.82 | AKR1B1 (0.56) | MPIPGK1PGK2PGDLPAR1 | |
| SCHEMBL18341376 | 0.82 | MPI (0.55) | MPIPGK1PGK2PGDLPAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190161786-A1 | METHODS FOR SELECTING ENZYMES HAVING PROTEASE ACTIVITY | NOVOZYMES A/S (DK) | 2019-05-30 | — | — | US | disclosed |
| EP-3440207-A1 | METHODS FOR SELECTING ENZYMES HAVING PROTEASE ACTIVITY | Novozymes A/S (DK) | 2019-02-13 | — | — | EP | disclosed |
| US-20180355404-A1 | METHODS FOR SELECTING ENZYMES HAVING LIPASE ACTIVITY | NOVOZYMES A/S (DK) | 2018-12-13 | — | — | US | disclosed |
| EP-2751261-B1 | DEHYDROGENASE VARIANTS AND POLYNUCLEOTIDES ENCODING SAME | NOVOZYMES INC (US) | 2018-08-29 | — | — | EP | disclosed |
| US-20180073017-A1 | METHODS FOR SELECTING ENZYMES HAVING ENHANCED ACTIVITY | NOVOZYMES A/S (DK) | 2018-03-15 | — | — | US | disclosed |
| EP-3280817-A2 | METHODS FOR SELECTING ENZYMES HAVING ENHANCED ACTIVITY | Novozymes A/S (DK) | 2018-02-14 | — | — | EP | disclosed |
| EP-3280818-A2 | METHODS FOR SELECTING ENZYMES HAVING LIPASE ACTIVITY | Novozymes A/S (DK) | 2018-02-14 | — | — | EP | disclosed |
| WO-2017177153-A1 | METHODS FOR SELECTING ENZYMES HAVING PROTEASE ACTIVITY | NOVOZYMES A/S (DK) | 2017-10-12 | — | — | WO | disclosed |
| US-9404091-B2 | Dehydrogenase variants and polynucleotides encoding same | NOVOZYMES, INC. (US) | 2016-08-02 | — | — | US | disclosed |
| US-20160017296-A1 | Dehydrogenase Variants and Polynucleotides Encoding Same | NOVOZYMES INC (US) | 2016-01-21 | — | — | US | disclosed |
| US-9163220-B2 | Dehydrogenase variants and polynucleotides encoding same | NOVOZYMES A/S (DK) | 2015-10-20 | — | — | US | disclosed |
| US-20140212938-A1 | Dehydrogenase Variants and Polynucleotides Encoding Same | NOVOZYMES A/S (DK) | 2014-07-31 | — | — | US | disclosed |
| EP-2751261-A1 | DEHYDROGENASE VARIANTS AND POLYNUCLEOTIDES ENCODING SAME | Novozymes, Inc. (US) | 2014-07-09 | — | — | EP | disclosed |
| US-8728788-B1 | Dehydrogenase variants and polynucleotides encoding same | NOVOZYMES A/S (DK) | 2014-05-20 | — | — | US | disclosed |
| WO-2013049073-A1 | DEHYDROGENASE VARIANTS AND POLYNUCLEOTIDES ENCODING SAME | NOVOZYMES, INC. (US) | 2013-04-04 | — | — | WO | disclosed |